DIESE DOI-METADATEN WURDEN ZULETZT AKTUALISIERT AM: 2024-01-10 22:57
Vollständiger Titel
RIVISTA SPERIMENTALE DI FRENIATRIA
Verlag
FrancoAngeli
ISSN
1129-6437 (Gedruckte Zeitschrift)
1972-5582 (Online-Zeitschrift)
Nummer der Ausgabe
2
Andere Beschreibung der Ausgabe
2
Erscheinungsdatum der Ausgabe (YYYY/MM)
2016/07
Vollständiger Titel
Le nuove frontiere dell'intervento integrato farmacologico e psicosociale per il trattamento dei disturbi da uso di sostanze
Von (Autor)
Erste Seite
103
Letzte Seite
125
Sprache des Textes
Italienisch
Erscheinungsdatum
2016/07
Copyright
2016 FrancoAngeli srl
Vorwort
In forma di intervista i tre Coautori espongono dati e riflessioni provenienti dalla loro esperienza di Ricerca e di Clinica in tema di nuovi trattamenti farmacologici dei disturbi da uso di alcol e altre droghe. Una delle chiavi di lettura comuni dei loro tre contributi è la reversione del neuroadattamento a tali sostanze mediante appositi percorsi di cura integrati, farmacologici e psicosociali, che consentono di manipolare terapeuticamente le memorie dell'addiction. Gli obiettivi di tale approccio possono essere tanto la cessazione radicale dell' uso di sostanze psicoattive quanto la riduzione della compulsione al loro consumo. Il misuso degli analgesici oppioidi e più in generale le dipendenze iatrogene sono pure trattati in quanto costituenti l'aspetto più inquietante delle nuove frontiere della Clinica dell'addiction.
Unstructured Zitierung
[1] Lovaste R, Colasante E, Pitino A, Gori M. Valutazione dell’efficacia dei trattamenti metadonici effettuati nei SerD della Provincia Autonoma di Trento. Mission 2010; 29:53-9.
Unstructured Zitierung
[2] Silins E, Sannibale C, Larney S, Wodak A, Mattick R. Residential detoxification: essential for marginalised, severely
alcohol- and drug-dependent individuals. Drug Alcohol Rev 2008; 27:414-9.
https://doi.org/10.1080/09595230701750650
Unstructured Zitierung
[3] Smyth BP, Barry J, Keenan E, Ducray K. Lapse and relapse following inpatient treatment of opiate dependence. Ir Med J 2010; 103:176-9. [4] Amodeo M, Lundgren L, Chassler D, Witas J. High-frequency users of detoxification: who are they? Subst Use Misuse 2008; 43:839-49.
Unstructured Zitierung
[5] Lugoboni F, Quaglio GL, Faccini M, Pajusco B, Casari R, Albero A, Mezzelani P. Un’Unità di degenza interamente dedicata alla dipendenza da sostanze: i primi 10 anni di attività di Medicina delle Dipendenze del Policlinico di Verona. Mission 2010; 31:9-15.
Unstructured Zitierung
[6] Maremmani I, Cibin M, Pani PP, Rossi A, Turchetti G. Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder. Int
J Environ Res Public Health 2015; 12 (11): 14828-41.
https://doi.org/10.3390/ijerph121114828
Unstructured Zitierung
[7] Soares Pinto SP, Zambon A, Cibin M, et al. Poliabuso e doppia diagnosi nelle residenzialità alcologiche ospedaliere: caratteristiche dei pazienti e dei percorsi terapeutici/riabilitativi. Mission 2013; 37: 19-28.
Unstructured Zitierung
[8] Chiamulera C. Cue reactivity in nicotine and tobacco dependence: a “multipleaction” model of nicotine as a primary reinforcement
and as an enhancer of the effects of smoking-associated stimuli. Brain Res Brain Res Rev. 2005; 48(1):74-97.
https://doi.org/10.1016/j.brainresrev.2004.08.005
Unstructured Zitierung
[9] Kalivas PW, O’Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008; 33(1):166-80.
https://doi.org/10.1038/sj.npp.1301564
Unstructured Zitierung
[10] Sandrini M, Cohen LG, Censor N. Modulating reconsolidation: a link to causal systems-level dynamics of human memories.
Trends Cogn Sci. 2015; 19(8): 475-82.
https://doi.org/10.1016/j.tics.2015.06.002
Unstructured Zitierung
[11] Casartelli L, Chiamulera C. The motor way: Clinical implications of understanding and shaping actions with the motor
system in autism and drug addiction. Cogn Affect Behav Neurosci. 2016; 16(2):191-206.
https://doi.org/10.3758/s13415-015-0399-7
Unstructured Zitierung
[12] Chiamulera C, Cibin M. Drinking reduction and reversibility of neuroadaptation in alcoholism. J Psychopharmacol. 2014;
28(8):810-2.
https://doi.org/10.1177/0269881114538544
Unstructured Zitierung
[13] Piazza PV, Deroche-Gamonet V. A multistep general theory of transition to addiction. Psychopharmacology 2013; 229(3):387-413.
https://doi.org/10.1007/s00213-013-3224-4
Unstructured Zitierung
[14] Chiamulera C, Hinnenthal I, Auber A, Cibin M. Reconsolidation of maladaptive memories as a therapeutic target: pre-clinical
data and clinical approaches. Front Psychiatry 2014; 5:107.
https://doi.org/10.3389/fpsyt.2014.00107
Unstructured Zitierung
[15] Kim J, Song B, Hong I, Kim J, Lee J, Park S, Eom JY, Lee CJ, Lee S, Choi S. Reactivation of fear memory renders consolidated
amygdala synapses labile. J Neurosci. 2010; 30(28): 9631-40.
https://doi.org/10.1523/JNEUROSCI.0940-10.2010
Unstructured Zitierung
[16] Monfils MH, Cowansage KK, Klann E, LeDoux JE. Extinction-reconsolidation boundaries: key to persistent attenuation of
fear memories. Science 2009; 324 (5929): 951-5.
https://doi.org/10.1126/science.1167975
Unstructured Zitierung
[17] Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA. Preventing the return of fear in humans using reconsolidation
update mechanisms. Nature 2010; 463 (7277): 49-53.
https://doi.org/10.1038/nature08637
Unstructured Zitierung
[18] Nader K, Schafe GE, Le Doux JE. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval.
Nature 2000; 406 (6797): 722-6.
https://doi.org/10.1038/35021052
Unstructured Zitierung
[19] Nader K. Memory traces unbound. Trends Neurosci. 2003; 26(2): 65-72. [20] Torregrossa MM, Taylor JR. Learning to forget: manipulating extinction and reconsolidation processes to treat addiction. Psychopharmacology 2013; 226(4):659-72.
Unstructured Zitierung
[21] Auber A, Tedesco V, Jones CE, Monfils MH, Chiamulera C. Post-retrieval extinction as reconsolidation interference: methodological
issues or boundary conditions? Psychopharmacology 2013; 226(4): 631-47.
https://doi.org/10.1007/s00213-013-3004-1
Unstructured Zitierung
[22] Agren T. Human reconsolidation: a reactivation and update. Brain Res Bull. 2014; 105:70-82.
https://doi.org/10.1016/j.brainresbull.2013.12.010
Unstructured Zitierung
[23] Cai WH, Blundell J, Han J, Greene RW, Powell CM. Postreactivation glucocorticoids impair recall of established fear memory.
J Neurosci. 2006; 26(37): 9560-6.
https://doi.org/10.1523/JNEUROSCI.2397-06.2006
Unstructured Zitierung
[25] Rodriguez WA, Rodriguez SB, Phillips MY, Martinez JL Jr. Post-reactivation cocaine administration facilitates later acquisition
of an avoidance response in rats. Behav Brain Res. 1993; 59(1-2):125-9.
https://doi.org/10.1016/0166-4328(93)90158-M
Unstructured Zitierung
[26] Logan DE, Marlatt GA. Harm reduction therapy: a practice-friendly review of research. J Clin Psychol. 2010; 66(2):201-14.
https://doi.org/10.1002/jclp.20669
Unstructured Zitierung
[27] Sinclair JD Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol
and Alcoholism 2001; 36(1): 2-10.
https://doi.org/10.1093/alcalc/36.1.2
Unstructured Zitierung
[28] Fantozzi F, Sinclair D. La ricaduta nell’alcol: un concetto vincente, ma … in via di estinzione? Personalità/Dipendenze 2004; 10: 219-243.
Unstructured Zitierung
[29] Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group, A randomised, double-blind, placebo-controlled,
efficacy study of nalmefene, asneeded use, in patients with alcohol dependence. Eur Neuropsychopharmacol. 2013; 23(11):1432-42.
https://doi.org/10.1016/j.euroneuro.2013.02.006
Unstructured Zitierung
[30] Van den Brink W, Sørensen P, Torup L, Mann K, Gual A, for the SENSE Study Group. Long-term efficacy, tolerability and
safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study. J Psychopharmacol.
2014; 28(8):733-744.
https://doi.org/10.1177/0269881114527362
Unstructured Zitierung
[31] Bowen S, Chawla N, Marlatt GA. Mindfulness e Comportamenti di Dipendenza. Milano: Raffaello Cortina ed.; 2013.
Unstructured Zitierung
[32] Shapiro F, Vogelmann-Sine S, Sine LF. Eye movement desensitization and reprocessing: treating trauma and substance abuse.
J Psychoactive Drugs 1994; 26(4):379-91.
https://doi.org/10.1080/02791072.1994.10472458
Unstructured Zitierung
[33] Hase M, Shallmayer S, Sack M, EMDR reprocessing of the Addiction
Unstructured Zitierung
Memory: pretreatment, Postreatment and 1-month follow up. J EMDR
Unstructured Zitierung
Practice and research 2008; 2,3:170-179.
Unstructured Zitierung
[34] Hinnenthal I, Cibin M. Il trattamento residenziale breve delle Dipendenze da
Unstructured Zitierung
Alcol e Cocaina: il modello Soranzo. Torino: SEED Editore; 2011.
Unstructured Zitierung
[35] Caputo F, Bernardi M. Medications Acting on the GABA System in the
Unstructured Zitierung
Treatment of Alcoholic Patients. Curr Pharm Des, 2010; 16: 2118-2125. [36] Chick J, Nutt DJ. Substitution therapy for alcoholism: time for a reappraisal? J Psychopharmacol 2012; 26:205-212.
Unstructured Zitierung
[37] Keating GM. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in maintenance of abstinence in alcohol
dependence. Clin Drug Investig. 2014; 34: 63-80.
https://doi.org/10.1007/s40261-013-0158-x
Unstructured Zitierung
[38] Quaglio GL, Pattaro C, Gerra G, Mezzelani P, Montanari L, Des Jarlais DC, Lugoboni F. Buprenorphine in maintanance treatment: experience among italian physician in drug addiction centers. Am J Addiction 2010; 10:1-9
Unstructured Zitierung
[39] Kasliwal R, Wilton LV, Shakir SAW. Safety and drug utilization profile of varenicline as used in general practice in
England. Drug Saf 2009; 32:499-507.
https://doi.org/10.2165/00002018-200932060-00006
Unstructured Zitierung
[41] Lader M. Benzodiazepines revisited--will we ever learn? Addiction 2011; 106: 2086-2109.
https://doi.org/10.1111/j.1360-0443.2011.03563.x
Unstructured Zitierung
[42] Madrak LN, Rosenberg M. Zolpidem abuse. Am J Psychiatry 2001; 158: 1330-1.
https://doi.org/10.1176/appi.ajp.158.8.1330-a
Unstructured Zitierung
[43] Faccini M, Leone R, Pajusco B, Quaglio G, Casari R, Albero A, Donati M, Lugoboni F. Lormetazepam Addiction. Data Analysis from an Italian Medical Unit for Addiction. Risk manage Healthcare Pol 2012; 5:43-8.
Unstructured Zitierung
[44] Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse
and mortality in the United States. N. Engl. J. Med. 2015; 372:241-248.
https://doi.org/10.1056/NEJMsa1406143
Unstructured Zitierung
[45] Weisberg DF, Becker WC, Fiellin DA, Stannard C. Prescription opioid misuse in the United States and the United Kingdom:
cautionary lessons. Int. J. Drug Policy 2014; 25: 1124-1130.
https://doi.org/10.1016/j.drugpo.2014.07.009
Unstructured Zitierung
[46] Manchikanti L, Helm II S, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV. Opioid epidemic in the United States. Pain Physician 2012; 15: 9-38.
Unstructured Zitierung
[47] Lugoboni F, Faccini M, Casari R, Guadagnini P, Delaini P. La formazione sulle dipendenze patologiche: possono i SerD avere una funzione didattica vicariante nei confronti dell’Università? Alcune opportunità da non tralasciare. Mission 2013; 37: 55-60.